PATENT CLAIM ANALYSIS

Application Number: 16044320
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["546", "268100"]

Abstract:
The invention relates to a compound of formula (I) wherein A and R 1  to R 4  are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

Claim (Index 17):
The compound of  claim 1 , wherein the compound is:\n N-[3-(1-azido-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-5-cyclopropyl-6-(cyclopropylmethoxy)pyrazine-2-carboxamide; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.51724
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14868305', '15050753', '14648418', '13486057', '15478435']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8238525918974274
- 35 USC 102 Novelty (BERT): 0.5442955460136106
- Combined Prediction Score: 0.7958968873090457
- Mean Citation Score: 374.275046
- Max Citation Score: 408.03818
- Similarity Product: 327.4105623815202

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test